Compare Cytokinetics Inc (CYTK) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Ginkgo Bioworks Holdings Inc — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M). The key difference: Cytokinetics Inc is far larger — about 21× Ginkgo Bioworks Holdings Inc's market cap, and Cytokinetics Inc is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| CYTK | DNA | |
|---|---|---|
Market Cap | $10.63B | $505.73M |
Sector | Technology | Health |
52-Week High | $87.26 | $16.14 |
52-Week Low | $34.31 | $5.48 |
Enterprise Value | $10.74B | $607.68M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →
